Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

Susan K. Quella, Charles L. Loprinzi, Jeff A. Sloan, Nancy L. Vaught, Wanda L. DeKrey, Tammy Fischer, Gwen Finck, Nancy Pierson, Thomas Pisansky

Research output: Contribution to journalArticle

136 Scopus citations

Abstract

BACKGROUND. Hot flashes are often a troublesome symptom in breast carcinoma survivors and men with prostate carcinoma who have undergone androgen deprivation therapy. A previous clinical study demonstrated that, on a short term basis, low dose megestrol acetate markedly reduced hot flashes and was well tolerated. Little information has been available regarding the long term use of low dose megestrol acetate for hot flashes. METHODS. Patients previously enrolled on a randomized placebo-controlled trial that evaluated the short term use of megestrol acetate for hot flashes were contacted and interviewed by telephone. RESULTS. A total of 132 persons were contacted. Nine percent of the patients discontinued megestrol acetate after resolution of their hot flashes. Forty-five percent of the patients contacted were continuing to utilize megestrol acetate approximately 3 years beyond the conclusion of the 1992 study. Three-quarters of these patients were utilizing ≤20 mg of megestrol acetate per day. Potential toxicities attributed to megestrol acetate included episodes of chills, appetite stimulation/weight gain, vaginal bleeding, and carpal tunnel syndrome symptoms. CONCLUSIONS. A substantial proportion of patients continue to use megestrol acetate for periods of up to 3 years or longer with continued control of hot flashes. This treatment appears to be relatively well tolerated.

Original languageEnglish (US)
Pages (from-to)1784-1788
Number of pages5
JournalCancer
Volume82
Issue number9
DOIs
StatePublished - May 1 1998

Keywords

  • Breast carcinoma survivors
  • Hot flashes
  • Megestrol acetate

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes'. Together they form a unique fingerprint.

  • Cite this